首页> 外文期刊>BMC Urology >Prognostic significance of epidermal growth factor receptor (EGFR) over expression in urothelial carcinoma of urinary bladder
【24h】

Prognostic significance of epidermal growth factor receptor (EGFR) over expression in urothelial carcinoma of urinary bladder

机译:表皮生长因子受体(EGFR)在膀胱尿路上皮癌中表达的预后意义

获取原文
           

摘要

Epidermal growth factor receptor (EGFR) has been shown to have abnormal expression in many human cancers and is considered as a marker of poor prognosis. Frequency of over expression in bladder cancer has not been studied in our population; therefore we aimed to evaluate the frequency and prognostic significance of EGFR immunohistochemical expression in locoregional population. We performed EGFR immunohistochemistry on 126 cases of bladder cancer and association of EGFR expression with tumor grade, lamina propria invasion, deep muscle invasion and recurrence of disease was evaluated. High EGFR expression was noted in 26.2% (33 cases), 15.1% (19 cases) and 58.7% (74 cases) revealed low and no EGFR expression respectively. Significant association of EGFR expression was noted with tumor grade, lamina propria invasion, deep muscle invasion and recurrence status while no significant association was seen with age, gender and overall survival. Kaplan- Meier curves revealed significant association of EGFR expression with recurrence while no significant association was seen with overall survival. Significant association of EGFR overexpression with tumor grade, muscularis propria invasion and recurrence signifies its prognostic value; therefore EGFR can be used as a prognostic biomarker in Urothelial bladder carcinoma.
机译:表皮生长因子受体(EGFR)已被证明在许多人类癌症中表达异常,被认为是预后不良的标志。尚未在我们的人群中研究膀胱癌中过度表达的频率。因此,我们旨在评估局部人群中EGFR免疫组织化学表达的频率和预后意义。我们对126例膀胱癌患者进行了EGFR免疫组化研究,并评估了EGFR表达与肿瘤等级,固有层浸润,深部肌肉浸润和疾病复发的关系。 EGFR的高表达分别为26.2%(33例),15.1%(19例)和58.7%(74例),表明EGFR低表达和无EGFR表达。 EGFR表达与肿瘤等级,固有层浸润,深层肌肉浸润和复发状态显着相关,而与年龄,性别和总生存率无显着相关性。 Kaplan-Meier曲线显示EGFR表达与复发显着相关,而与总生存率无显着相关。 EGFR过度表达与肿瘤分级,固有肌层浸润和复发的显着相关表明其预后价值;因此,EGFR可作为尿道上皮癌的预后生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号